Prevalência, fatores de risco e caracterização genética dos vírus linfotrópico de células T humana tipo 1 e 2 em pacientes infectados pelo vírus da imunodeficiência humana tipo 1 nas Cidades de Ribeirão Preto e São Paulo

Kleine Neto, Walter; Sanabani, Sabri Saeed; Jamal, Leda Fátima; Sabino, Ester Cerdeira.
Rev. Soc. Bras. Med. Trop ; 42(3): 264-270, May-June 2009. ilus, tab
Artigo em Português | LILACS | ID: lil-522254

Documentos relacionados

  1. Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?
  2. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
  3. Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T-cell leukaemia virus type-1 and type-2 infection in a London teaching hospital with a large solid organ transplant centre.
  4. Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy.
  5. Decline in human T-cell lymphotropic virus seroprevalence in blood donors from Minas Gerais, Brazil over a 12-year period (2006-2017).
  6. Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations.
  7. Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil.
  8. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
  9. The prevalence of human T-cell leukemia virus in blood donors in China.
  10. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.